Moringa and Breast Milk: What the Trials Found


Moringa leaf has a long reputation as a milk food. It is used to support breast-milk supply in the Philippines, where the tree is called malunggay, and the same custom is reported from Indonesia and elsewhere in Asia. The Moringa Benefits page sums up the milk-supply evidence in a few lines: traditional use with weak supporting trials. This page goes one level deeper. It takes the human studies that can be read in PubMed one at a time — who was studied, how much moringa was given, for how long, and what was actually measured — and then sets out what the systematic reviews make of them.

Two recent trials frame the question. A 3-month trial in Kenya found that mothers given moringa expressed more milk than mothers who were not. A double-blind trial in Thailand found no significant difference in milk volume on the third day after birth. Both are described in full below, along with the reviews, the safety record, and the long list of things nobody has yet measured.


Table of Contents

  1. Moringa Leaf Has a Long Tradition as a Milk Food
  2. The Kenyan Trial Ran for Three Months
  3. The Thai Trial Found No Significant Difference
  4. An Indonesian Soup Study Used a Weaker Design
  5. Reviews Rate the Evidence as Low or Very Low Certainty
  6. Moringa Has Rarely Been Tested Against Another Galactagogue
  7. What the Studies Measured and What They Left Out
  8. Safety Findings for Mother and Baby
  9. What Is Still Not Known
  10. Key Research Papers
  11. Connections
  12. Featured Videos

Moringa Leaf Has a Long Tradition as a Milk Food

A galactagogue is any food, herb or drug taken to increase breast-milk supply. LactMed, the U.S. National Institute of Child Health and Human Development's database on medicines and breastfeeding, records that moringa leaf "has been used as a galactogogue in Asia, particularly in the Philippines where it is called malunggay," and that the leaves "are widely used as a food and medicine in Asia and Africa."

Researchers in other countries describe the same custom. An Indonesian research team writes that moringa "has traditionally been used to increase breast milk production." A team studying the plant in rats notes that in various cultures it is used by pregnant women to increase milk production. A 2025 systematic review attributes the traditional use to the leaf's micronutrient and phytosterol content — that is the reviewers' explanation of the tradition, not a tested mechanism.

The traditional milk food is the leaf; the Indonesian study below served it as a vegetable soup. That matters for safety: the leaf and the root are chemically very different parts of the plant, as the safety section below explains. The story of how the Filipino custom first reached clinical trials, including the earliest Philippine studies, is told on the Moringa History page.

Back to Table of Contents

The Kenyan Trial Ran for Three Months

The longest trial described on this page was carried out in Kisumu County, Kenya, and published in 2025. Its design was published as a protocol in 2022.

What it found

The authors' own conclusion is careful: in this population, three months of maternal moringa "was associated with increased expressed milk output and higher circulating infant IGF-1 without impacting infant growth," and "additional studies are needed to understand the mechanisms driving these effects and their influence on long-term health."

The vitamin A results from the same trial

A companion paper from the same Kenyan trial looked at vitamin A, which an exclusively breastfed baby receives only through milk. The authors describe moringa leaf as a good food source of provitamin A and other carotenoids. Milk and blood samples were completed by 44 pairs (88%). Four mothers (9%) had vitamin A deficiency and 11 (25%) were vitamin A insufficient. Alpha-carotene in milk was higher in the moringa group — but it was already higher at the start (p = 0.024) as well as at the end (p = 0.014). The authors conclude that maternal moringa "did not impact concentration of milk vitamin A and resulted in limited increase in milk carotenoids in this cohort."

Reading the Kenyan trial carefully

Back to Table of Contents

The Thai Trial Found No Significant Difference

A double-blind trial from Bangkok, Thailand, published in 2022, tested moringa leaf capsules in the first days after birth.

What it found

The paper's own conclusion holds both results side by side: "even 900 mg/day of the Moringa oleifera leaf could not significantly increase breast milk volume in early postpartum mothers," yet the authors still write that moringa leaf "may be used as a galactagogue herb." Readers can see both statements in the abstract. As a test of its main question, the trial is a null result.

The Thai and Kenyan trials differ in almost every way — 900 mg of capsules against 20 g of food powder, a day-3 measurement against a 3-month trial, day-3 volume against 24-hour expressed volume, double-blind against single-blind. They do not contradict each other so much as answer different questions.

Back to Table of Contents

An Indonesian Soup Study Used a Weaker Design

A 2024 study from rural Batang-Batang District, Indonesia, tested moringa as food rather than as a supplement.

In the soup group, 57% of mothers had adequate milk production before the study and 76% afterwards. The authors report a significant difference on a Mann-Whitney U test (printed as p = 0.000). Without randomisation, blinding or a measured milk volume, the study shows an association in a small group rather than a tested effect.

Back to Table of Contents

Reviews Rate the Evidence as Low or Very Low Certainty

Several groups have tried to add up the moringa milk studies. They differ in what they include, and so in how confident they sound, but none rates the evidence as high certainty.

The 2025 moringa-only systematic review

A 2025 review in Foods searched for randomised controlled trials of moringa leaf in postpartum women. Eight studies met its criteria, and the interventions lasted from 3 to 10 days. The reviewers report that moringa "increased significantly breast milk volume by up to 400 mL/day compared to controls," and that serum prolactin — the main milk-making hormone — rose "with a mean increase of 231.72 ng/mL." Most studies had low to moderate risk of bias; one had a high risk because it lacked blinding and used a subjective outcome. The reviewers call for "further longer-term studies" to establish optimal dosing, sustained effectiveness and safety.

The 2020 Cochrane review of all galactagogues

The Cochrane review covered 41 randomised trials involving 3005 mothers and 3006 infants, testing both drugs and natural galactagogues in mothers of healthy term babies. Moringa was among the natural products studied. Its findings for moringa are limited by the way the studies differed from one another:

The 2026 review in mothers of premature babies

A 2026 review in the European Journal of Clinical Nutrition looked only at randomised trials of herbal galactagogues in mothers who delivered prematurely, a group whose babies' risk of necrotising enterocolitis and sepsis is reduced by breast milk, and in which breastfeeding rates are lower than in term babies. Ten trials were included, each testing a different herb or mixture; two were at high risk of bias and the rest had "some concerns." The authors list moringa leaf capsules among five preparations with "low certainty evidence" of increased breast-milk production. The abstract gives mean differences in milk volume for four of the other preparations, but not for moringa.

Other reviews

Put together, the reviews agree on direction more than on confidence: most report more milk with moringa, but the trials are small and short, and the formal certainty ratings run from low to very low.

Back to Table of Contents

Moringa Has Rarely Been Tested Against Another Galactagogue

Most moringa studies compare it with a placebo or with nothing. The Cochrane review found eight studies that compared one galactagogue directly with another — moringa and domperidone among the products tested — but "there was only one small study for each match-up, so we do not know if one galactagogue is better than another for any outcome."

The drug side of the comparison has its own uncertainties. Domperidone and metoclopramide are prescription drugs that are sometimes prescribed to increase milk supply. In the Cochrane review, three trials of drugs (metoclopramide, domperidone and sulpiride; 151 participants) suggested they "may increase milk volume," by a mean difference of 63.82 mL, at low certainty. A 2024 network meta-analysis of 17 randomised trials found that domperidone increased daily milk volume in mothers of preterm infants compared with placebo (mean difference 88.30 mL a day), but not significantly in mothers of term infants, and that metoclopramide "was no better than the placebo" in either group.

These drug figures come from different trials, different mothers and different ways of measuring milk, so they cannot be lined up against the moringa figures as a head-to-head result. What can be said is that neither the drugs nor moringa have been compared with each other in a trial large enough to settle which, if either, works better.

The sister pages on Shatavari, Fennel, Fenugreek and Blessed Thistle examine the other well-known herbal galactagogues in the same way.

Back to Table of Contents

What the Studies Measured and What They Left Out

"Moringa increases milk" can mean very different things depending on what was counted. Across the studies on this page, the outcomes were:

Outcomes that matter most to families were rarely measured. For galactagogues in general, the Cochrane review found that the share of mothers still breastfeeding at 3, 4 and 6 months was barely reported, and it called for "a set of core outcomes to standardise infant weight and milk volume measurement" and "a strong basis for the dose and dosage form used." The doses in the moringa studies span from 0.5 g a day of leaf to 20 g a day of powder, and from three days to three months, which makes it hard to say what amount any finding refers to.

Back to Table of Contents

Safety Findings for Mother and Baby

What the human studies reported

LactMed states that "studies have found no serious short-term adverse effects in nursing mothers who ingested Moringa leaves or in their breastfed infants." A 2023 narrative review of 12 studies of moringa in pregnancy and breastfeeding reports that "none of the studies analysed reported contraindications to the use of the supplement during pregnancy and lactation." A 2015 safety review of moringa found that "no adverse effects were reported in association with human studies," and noted that "standardization of products is an issue." Across all natural galactagogues, the Cochrane review found adverse effects poorly reported, and those that were reported were minor complaints.

Short-term absence of reported harm is not the same as long-term safety data. LactMed notes that long-term benefit to breastfed infants "has not been well studied," and the 2025 systematic review lists safety among the questions still needing longer-term studies.

What the animal studies reported

In rats, leaf and seed flour given at 100 mg per kg of body weight through pregnancy and lactation did not affect the mothers' weight gain, did not harm the birth of the pups, and did not cause abortions or mutations in the offspring. In another rat study, a blend of three plant extracts that included moringa raised milk production at one of the doses tested — but with three plants in the blend, it says nothing about moringa alone, and nothing about women.

The root is not the leaf

Every trial on this page used the leaf. As set out on the Moringa Benefits page, the root and root bark concentrate alkaloids, and root bark has a traditional use as an abortifacient and to bring on menstruation; high-dose leaf supplements and concentrated extracts have no adequate safety data in pregnancy. A product label that names the leaf states the plant part; one that says only "moringa" does not.

Interactions reported for moringa

LactMed notes that dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration, and that "differences are often found between labeled and actual ingredients or their amounts," and that "clinical testing results on one product may not be applicable to other products." LactMed also states that galactagogues "should never replace evaluation and counseling on modifiable factors that affect milk production." Decisions about any supplement while breastfeeding belong with a clinician or lactation consultant.

Back to Table of Contents

What Is Still Not Known

Back to Table of Contents

Key Research Papers

  1. Attia SL, Owuor PM, Odhiambo SA, Mogaka JN, Ondondo R, Navarro IC, Schadler A, McQuerry K, Fuchs GJ 3rd, Williams JE, Scarrow KN, McGuire MA, McGuire MK, Waterman C. Effect of Maternal Moringa oleifera Leaf Supplementation on Maternal and Infant Nutritional Status and Human Milk Output: A Pilot Single-Blinded Cluster-Randomized Trial. Current Developments in Nutrition. 2025;9(11):107568. PubMed PMID: 41282517
  2. Attia SL, Odhiambo SA, Mogaka JN, Ondondo R, Schadler A, McQuerry K, Fuchs GJ 3rd, Williams JE, McGuire MK, Waterman C, Schulze K, Owuor PM. Impact of Maternal Moringa oleifera Leaf Supplementation on Milk and Serum Vitamin A and Carotenoid Concentrations in a Cohort of Breastfeeding Kenyan Women and Their Infants. Nutrients. 2024;16(19):3425. PubMed PMID: 39408390
  3. Mogaka JN, Owuor PM, Odhiambo S, Waterman C, McGuire MK, Fuchs GJ, Attia SL. Investigating the Impact of Moringa oleifera Supplemented to Kenyan Breastfeeding Mothers on Maternal and Infant Health: A Cluster Randomized Single-Blinded Controlled Pilot Trial Protocol. JPGN Reports. 2022;3(3):e237. PubMed PMID: 37168619
  4. Fungtammasan S, Phupong V. The effect of Moringa oleifera capsule in increasing breast milk volume in early postpartum patients: A double-blind, randomized controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology: X. 2022;16:100171. PubMed PMID: 36440058
  5. Yasin Z, Nawawi A, Wibowo A, Nadhiroh SR, Devy SR. Effects of Moringa oleifera on increasing breast milk in breastfeeding mothers with stunting toddlers in rural Batang-Batang District, Indonesia. African Journal of Reproductive Health. 2024;28(10s):34-4. PubMed PMID: 39635867
  6. Ammar M, Russo GL, Altamimi A, Altamimi M, Sabbah M, Al-Asmar A, Di Monaco R. Moringa oleifera Supplementation as a Natural Galactagogue: A Systematic Review on Its Role in Supporting Milk Volume and Prolactin Levels. Foods. 2025;14(14):2487. PubMed PMID: 40724308
  7. Foong SC, Tan ML, Foong WC, Marasco LA, Ho JJ, Ong JH. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database of Systematic Reviews. 2020;5(5):CD011505. PubMed PMID: 32421208
  8. Cragg A, Levene I, Darabi S, Willcox M. Herbal galactagogues to improve breastmilk production and lactation in mothers of preterm babies: a systematic review of clinical trials. European Journal of Clinical Nutrition. 2026;80(2):146-158. PubMed PMID: 41350450
  9. Brar S, Haugh C, Robertson N, Owuor PM, Waterman C, Fuchs GJ 3rd, Attia SL. The impact of Moringa oleifera leaf supplementation on human and animal nutrition, growth, and milk production: A systematic review. Phytotherapy Research. 2022;36(4):1600-1615. PubMed PMID: 35302264
  10. Bazzano AN, Hofer R, Thibeau S, Gillispie V, Jacobs M, Theall KP. A Review of Herbal and Pharmaceutical Galactagogues for Breast-Feeding. Ochsner Journal. 2016;16(4):511-524. PubMed PMID: 27999511
  11. Moringa. Drugs and Lactation Database (LactMed). National Institute of Child Health and Human Development. 2006. PubMed PMID: 30000959
  12. Si S, Zhao G, Song G, Liu J. Efficacy and safety of domperidone and metoclopramide on human milk production in postpartum mothers: a bayesian network meta-analysis of randomized controlled trials. BMC Pregnancy and Childbirth. 2024;24(1):819. PubMed PMID: 39695450
  13. Rotella R, Soriano JM, Llopis-González A, Morales-Suarez-Varela M. The Impact of Moringa oleifera Supplementation on Anemia and other Variables during Pregnancy and Breastfeeding: A Narrative Review. Nutrients. 2023;15(12):2674. PubMed PMID: 37375577
  14. Stohs SJ, Hartman MJ. Review of the Safety and Efficacy of Moringa oleifera. Phytotherapy Research. 2015;29(6):796-804. PubMed PMID: 25808883
  15. Dantas DL, Alves MDC, Dantas GMS, Campos ARN, Santana RAC, Soares JKB, Freitas JCR. Supplementation with Moringa oleifera Lam leaf and seed flour during the pregnancy and lactation period of Wistar rats: Maternal evaluation of initial and adult neurobehavioral development of the rat progeny. Journal of Ethnopharmacology. 2024;325:117904. PubMed PMID: 38342151
  16. Intan PR, Alegantina S, Isnawati A, Yunarto N, Ekawasti F, Rinendyaputri R, Sunarno S, Sani Y, Mariya SS, Handharyani E. Effects of a blend extract of Sauropus androgynus, Moringa oleifera, and Coleus amboinicus on milk production in lactating rats. Open Veterinary Journal. 2024;14(12):3630-3639. PubMed PMID: 39927372
  17. Monera TG, Wolfe AR, Maponga CC, Benet LZ, Guglielmo J. Moringa oleifera leaf extracts inhibit 6beta-hydroxylation of testosterone by CYP3A4. Journal of Infection in Developing Countries. 2008;2(5):379-83. PubMed PMID: 19745507
  18. Monera-Penduka TG, Maponga CC, Wolfe AR, Wiesner L, Morse GD, Nhachi CF. Effect of Moringa oleifera Lam. leaf powder on the pharmacokinetics of nevirapine in HIV-infected adults: a one sequence cross-over study. AIDS Research and Therapy. 2017;14:12. PubMed PMID: 28293270

PubMed Topic Searches

  1. PubMed: Moringa oleifera and breast milk
  2. PubMed: Moringa as a galactagogue
  3. PubMed: Moringa and prolactin
  4. PubMed: Herbal galactagogue reviews

Back to Table of Contents

Connections

Back to Table of Contents